Notices. Notice; correction
203 words·~1 min read·
/register/2011/06/06/2011-13871·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-1999-D-0742 (formerly Docket No. 1999D-4396)] Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration
(FDA)is correcting a notice that appeared in the **Federal Register** of May 24, 2011 (76 FR 30175). The document announced the availability of a draft guidance entitled “ Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators.”The document was published with an incorrect docket number. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148. SUPPLEMENTARY INFORMATION: In FR Doc. 2011-12623, appearing on page 30175, in the **Federal Register** of Tuesday, May 24, 2011, the following correction is made: 1. On page 30175, in the second column, in the Docket No. heading, “[Docket No. FDA-1999-D-0792] (Formerly FDA-1999-D-0792)” is corrected to read “[Docket No. FDA-1999-D-0742] (formerly Docket No. 1999D-4396)”. Dated: May 31, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011-13871 Filed 6-3-11; 8:45 am]